Do you want to read an article? Please log in or register.
Real-Life Clinical Outcomes of Benralizumab Treatment in Patients with Uncontrolled Severe Asthma and Coexisting Chronic Rhinosinusitis with Nasal Polyposis
Asthma
RECOMMENDED
Related content
RECOMMENDED
Asthma
Long-Term Clinical Remission on Benralizumab Treatment in Severe Eosinophilic Asthma: A Four-Year Real-Life Study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
J Clin Med
Quarato CMI, Tondo P, Lacedonia D, Soccio P, Pescatore D, Baccellieri ML, Lepore G, Foschino Barbaro MP, Scioscia G
doi: 10.3390/jcm14062075
RECOMMENDED
Asthma
Clinical response and on-treatment clinical remission with tezepelumab in a broad population of patients with severe, uncontrolled asthma: results over 2 years from the NAVIGATOR and DESTINATION studies
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Eur Respir J
Wechsler ME, Brusselle G, Virchow JC, Bourdin A, Kostikas K, Llanos JP, Roseti SL, Ambrose CS, Hunter G, Jackson DJ, Castro M, Lugogo N, Pavord ID, Martin N, Brightling CE
doi: 10.1183/13993003.00316-2024
RECOMMENDED
Asthma
Real-Life Evidence of Mepolizumab Treatment in Chronic Rhinosinusitis with Nasal Polyps: A Multicentric Study
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
J Clin Med
Cavaliere C, Loperfido A, Ciofalo A, Di Michele L, Begvarfaj E, Bellocchi G, Bugani M, de Vincentiis M, Greco A, Millarelli S, Plath M, Sculco E, Masieri S
doi: 10.3390/jcm13123575
ERS 2024
Asthma
BEHAVE: Benralizumab reduces exacerbations and improves asthma control in real-world patients with severe asthma
Asthma
ICS use trajectories in severe asthma patients on benralizumab: real-life data from 3-years follow-up
Respir Med
Pini L, Caminati M, Maule M, Bagnasco D, Beghè B, Bondi B, Braido F, Cameli P, Caruso C, Crimi C, El Masri Y, Giordani J, Guarnieri G, Latorre M, Mastrototaro A, Menzella F, Micheletto C, Pini A, Piras S, Spanevello A, Vianello A, Visca D, Zappa M, Zurlo M, Paggiaro P, Blasi F, Canonica GW, Senna G, Benoni R, SANI study group
doi: 10.1016/j.rmed.2025.108198
Asthma
Costs of Oral Corticosteroid Use in Patients with Severe Asthma With/Without Chronic Rhinosinusitis with Nasal Polyps: Data from the Italian SANI Registry
Adv Ther
Heffler E, Blasi F, Paggiaro P, Canonica GW
doi: 10.1007/s12325-024-03071-w
RECOMMENDED
Asthma
Clinical importance of patient-reported outcome measures in severe asthma: results from U-BIOPRED
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Health Qual Life Outcomes
Meys R, Franssen FME, Van 't Hul AJ, Bakke PS, Caruso M, Dahlén B, Fowler SJ, Geiser T, Howarth PH, Horváth I, Krug N, Behndig AF, Singer F, Musial J, Shaw DE, Montuschi P, Zee AHM, Sterk PJ, Roberts G, Kermani NZ, Incalzi RA, Louis R, Andersson LI, Wagers SS, Dahlén SE, Chung KF, Adcock IM, Spruit MA, U-BIOPRED Study Group
doi: 10.1186/s12955-024-02321-3
AsthmaRespiratory Tract Infection
Clinical response and remission in patients treated with dupilumab for severe asthma: Results from the nationwide Danish Severe Asthma Register
Respir Med
Hansen S, Håkansson KEJ, Soendergaard MB, Bjerrum AS, Schmid JM, Johansson SL, Rasmussen LM, Johnsen CR, von Bülow A, Bonnesen B, Krogh NS, Hilberg O, Dongo L, Vijdea R, Ulrik CS, Porsbjerg C
doi: 10.1016/j.rmed.2025.108203
Asthma
Real-Life Effectiveness of Budesonide/Formoterol as Maintenance and Reliever Treatment via the Elpenhaler(®) Device in Patients with Asthma: The NOTOS Observational Study
J Asthma Allergy
Gogali A, Rovina N, Samitas K, Steiropoulos P, Potonos D, Bertoli M, Papanastasiou P, Ginis A, Kostikas K
doi: 10.2147/JAA.S517932